Evolus to Participate in Two Upcoming Investor Conferences
March 02 2021 - 4:05PM
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a
customer-centric approach focused on delivering breakthrough
products, today announced that members of management will be
participating in two upcoming virtual investor conferences.
Event: |
H.C.
Wainwright Global Life Sciences Conference |
Format: |
Fireside Chat & 1x1 Meetings |
Date: |
Tuesday, March 9, 2021 |
Time: |
7:00am ET |
Location: |
Webcast Link |
|
|
Event: |
Barclays Global Healthcare Conference |
Format: |
Fireside Chat & 1x1 Meetings |
Date: |
Wednesday, March 10, 2021 |
Time: |
1:15pm – 1:40pm ET |
Location: |
Webcast Link |
Audio webcasts of Evolus’ fireside chats at the H.C. Wainwright
Global Life Sciences Conference and Barclays Global Healthcare
Conference will be available on the investor relations section of
Evolus’ website at investors.evolus.com. Replays of the webcasts
will be available for 90 days after the date of the
presentation.
About Evolus, Inc.
Evolus is a performance beauty company with a
customer-centric approach focused on delivering breakthrough
products. In 2019, the U.S. Food and Drug
Administration approved Jeuveau® (prabotulinumtoxinA-xvfs),
the first and only neurotoxin dedicated exclusively to aesthetics
and manufactured in a state-of-the-art facility using Hi-Pure™
technology. Jeuveau® is powered by Evolus' unique
technology platform and is designed to transform the aesthetic
market by eliminating the friction points existing for customers
today. Visit us at: www.evolus.com.
Jeuveau® is a registered trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Evolus, Inc. Contacts:
Investor Contact:Ashwin Agarwal, Evolus, Inc.Vice President,
Finance, Investor Relations & TreasuryTel:
+1-949-284-4559Email: IR@Evolus.com
Media Contact:Crystal Muilenburg, Evolus, Inc.Chief Marketing
OfficerTel: +1-949-284-4506Email: media@evolus.com
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From Apr 2023 to Apr 2024